spacer
spacer

PDBsum entry 1evs

Go to PDB code: 
protein links
Cytokine PDB id
1evs

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
163 a.a.
Waters ×116
PDB id:
1evs
Name: Cytokine
Title: Crystal structure of human oncostatin m
Structure: Oncostatin m. Chain: a. Engineered: yes. Other_details: c-terminal truncation
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562.
Resolution:
2.20Å     R-factor:   0.205     R-free:   0.261
Authors: M.C.Deller,K.R.Hudson,S.Ikemizu,J.Bravo,E.Y.Jones,J.K.Heath
Key ref:
M.C.Deller et al. (2000). Crystal structure and functional dissection of the cytostatic cytokine oncostatin M. Structure, 8, 863-874. PubMed id: 10997905 DOI: 10.1016/S0969-2126(00)00176-3
Date:
20-Apr-00     Release date:   13-Sep-00    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P13725  (ONCM_HUMAN) -  Oncostatin-M from Homo sapiens
Seq:
Struc:
252 a.a.
163 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 

 
DOI no: 10.1016/S0969-2126(00)00176-3 Structure 8:863-874 (2000)
PubMed id: 10997905  
 
 
Crystal structure and functional dissection of the cytostatic cytokine oncostatin M.
M.C.Deller, K.R.Hudson, S.Ikemizu, J.Bravo, E.Y.Jones, J.K.Heath.
 
  ABSTRACT  
 
BACKGROUND: The cytokine oncostatin M (OSM) inhibits growth of certain tumour-derived cells, induces proliferation in other cell types (e.g. haemangioblasts) and is a mediator of inflammatory responses. Its mechanism of action is via specific binding to gp130 and either the leukaemia inhibitory factor receptor (LIFR) or oncostatin M receptor (OSMR) systems at the cell surface to form an active signalling complex. RESULTS: We report here the crystal structure of human oncostatin M (hOSM) along with mutagenesis data which map the receptor-binding epitopes of the molecule. The structure was determined to a resolution of 2.2 A and conforms to the haematopoietin cytokine up-up-down-down four-helix bundle topology. The site 2 epitope, responsible for gp130 binding, is centred around Gly120 which forms a 'dimple' on the surface of the molecule located on helices A and C. The site 3 motif, responsible for LIFR and OSMR binding, consists of a protruding Phe160/Lys163 pair located at the start of helix D. CONCLUSIONS: The data presented allow functional dissection of the receptor-binding interfaces to atomic resolution. Modelling suggests that the gp130 residue Phe169 packs into the site 2 dimple in an analogous fashion to structurally equivalent residues at the growth hormone-growth hormone receptor interface, implying that certain key features may underlie recognition across the whole cytokine/receptor superfamily. Conversely, detailed comparison of the available structures suggests that variations on a common theme dictate the specificity of receptor-ligand interactions within the gp130 family of cytokines.
 
  Selected figure(s)  
 
Figure 5.
Figure 5. Complimentarity between the interaction surfaces of hOSM and gp130. The solvent-accessible surfaces of site 2 on hOSM (left) and the cognate binding site on gp130 (right) are displayed with areas contributed by residues implicated in binding highlighted as coloured patches. The orientation for hOSM site 2 is rotated 90° from that in Figure 4 whereas gp130 is rotated by 180° from its orientation relative to hOSM in the putative interaction complex, as in the opening of a book.
 
  The above figure is reprinted by permission from Cell Press: Structure (2000, 8, 863-874) copyright 2000.  
  Figure was selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
19920145 S.Le Saux, F.Rousseau, F.Barbier, E.Ravon, L.Grimaud, Y.Danger, J.Froger, S.Chevalier, and H.Gascan (2010).
Molecular dissection of human interleukin-31-mediated signal transduction through site-directed mutagenesis.
  J Biol Chem, 285, 3470-3477.  
18817510 X.Wang, P.Lupardus, S.L.Laporte, and K.C.Garcia (2009).
Structural biology of shared cytokine receptors.
  Annu Rev Immunol, 27, 29-60.  
16849177 U.Prisco, C.Leung, C.Xirouchaki, C.H.Jones, J.K.Heath, and R.E.Palmer (2005).
Residue-specific immobilization of protein molecules by size-selected clusters.
  J R Soc Interface, 2, 169-175.  
12707269 H.Plun-Favreau, D.Perret, C.Diveu, J.Froger, S.Chevalier, E.Lelièvre, H.Gascan, and M.Chabbert (2003).
Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
  J Biol Chem, 278, 27169-27179.  
12601009 J.Bitard, S.Daburon, L.Duplomb, F.Blanchard, P.Vuisio, Y.Jacques, A.Godard, J.K.Heath, J.F.Moreau, and J.L.Taupin (2003).
Mutations in the immunoglobulin-like domain of gp190, the leukemia inhibitory factor (LIF) receptor, increase or decrease its affinity for LIF.
  J Biol Chem, 278, 16253-16261.  
14527405 M.J.Boulanger, A.J.Bankovich, T.Kortemme, D.Baker, and K.C.Garcia (2003).
Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130.
  Mol Cell, 12, 577-589.
PDB code: 1pvh
11251120 D.Chow, X.He, A.L.Snow, S.Rose-John, and K.C.Garcia (2001).
Structure of an extracellular gp130 cytokine receptor signaling complex.
  Science, 291, 2150-2155.
PDB code: 1i1r
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer